TLP Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
TLP Group's PFE Position: Q3 2019 in Review
TLP Group increased its Pfizer (PFE) stake by 403% in Q3 2019, buying an estimated $350K and bringing the position to 11,400 shares worth $410K. The position accounts for 6.2% of the portfolio, ranked #5.
TLP Group first reported a position in PFE in Q4 2015 and has held it in 10 quarters since. The position peaked at $3.8M in Q4 2017. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.
- TLP Group held 11,400 shares of Pfizer worth $410K as of Q3 2019.
- TLP Group bought 9,135 Pfizer shares in Q3 2019, an estimated $350K.
- Pfizer made up 6.2% of TLP Group's portfolio in Q3 2019, its #5 holding.
- TLP Group first reported a position in Pfizer in Q4 2015 and has held it in 10 quarters since.
- TLP Group's Pfizer position peaked at $3.8M in Q4 2017.
- 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.
Based on TLP Group's 13F filing for Q3 2019, filed 11 Oct 2019.